Cargando…
Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study
OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364559/ https://www.ncbi.nlm.nih.gov/pubmed/37477876 http://dx.doi.org/10.1080/07853890.2023.2238186 |
_version_ | 1785076869609029632 |
---|---|
author | Bi, DeWu Liang, ChaoJuan Huang, XiaoXian Pan, HuiDan Qin, Yue Shi, XiMing Tang, YunHua Wang, Ying Zhao, MingMei Lin, JianYan Xie, ZhouHua Wen, LeMin Chen, ChaoYou Tang, XiKe Luo, XiaoCheng Shao, HongHua Luo, XiaoLu |
author_facet | Bi, DeWu Liang, ChaoJuan Huang, XiaoXian Pan, HuiDan Qin, Yue Shi, XiMing Tang, YunHua Wang, Ying Zhao, MingMei Lin, JianYan Xie, ZhouHua Wen, LeMin Chen, ChaoYou Tang, XiKe Luo, XiaoCheng Shao, HongHua Luo, XiaoLu |
author_sort | Bi, DeWu |
collection | PubMed |
description | OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive, cohort study among participants aged ≥ 18 years with suspected tuberculosis in Nanning, Guangxi, and China. Participants were tested for M. tuberculosis infection using commercially available antibodies against Mycobacterum tuberculosis. Specificity, sensitivity, negative and positive predictive values, and negative and positive likelihood ratios of the tests were determined. Sputum specimens and bronchoalveolar lavage fluid were sent for mycobacterial culture, Xpert MTB/RIF assay, and cell-free M. tuberculosis DNA or RNA assay. Blood samples were used for IGRAs, T-cell counts (CD3 + CD4+ and CD3 + CD8+), and antibodies to tuberculosis test. RESULTS: Of the 1857 participants enrolled in this study, 1772 were included in the analyses, among which, 1311 were diagnosed with active tuberculosis. The specificity of antibody against 16kD for active tuberculosis was 92.7% (95% confidence interval [CI]: 89.3–95.4) with a positive likelihood ratio for active tuberculosis cases of 3.1 (95% CI: 2.1–4.7), which was higher than that of antibody to Rv1636 (90.5% [95% CI: 86.6–93.5]), antibody to 38kD (89.5% [95% CI: 85.5–92.7]), antibody against CFP-10 (82.6% [95% CI: 77.9–86.7]), and antibody against LAM (79.3% [95% CI: 74.3–83.7]). Sensitivity ranged from 15.8% (95% CI: 13.9–17.9) for antibody against Rv1636 to 32.9% (95% CI: 30.4–35.6) for antibody to LAM. CONCLUSIONS: Commercially available antibodies against to Mycobacterium tuberculosis do not have sufficient sensitivity for the diagnostic evaluation of active tuberculosis. However, antibody against Rv1636 and 16kD may have sufficiently high specificities, high positive likelihood ratios, and correspondingly high positive predictive values to facilitate the rule-in of active tuberculosis. |
format | Online Article Text |
id | pubmed-10364559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-103645592023-07-25 Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study Bi, DeWu Liang, ChaoJuan Huang, XiaoXian Pan, HuiDan Qin, Yue Shi, XiMing Tang, YunHua Wang, Ying Zhao, MingMei Lin, JianYan Xie, ZhouHua Wen, LeMin Chen, ChaoYou Tang, XiKe Luo, XiaoCheng Shao, HongHua Luo, XiaoLu Ann Med Infectious Diseases OBJECTIVES: We aimed to investigate clinical uncertainties by characterizing the accuracy and utility of commercially available antibodies of Mycobacterium tuberculosis in the diagnostic assessment of suspected tuberculosis in high-burden countries. METHODS: We conducted a retrospective, descriptive, cohort study among participants aged ≥ 18 years with suspected tuberculosis in Nanning, Guangxi, and China. Participants were tested for M. tuberculosis infection using commercially available antibodies against Mycobacterum tuberculosis. Specificity, sensitivity, negative and positive predictive values, and negative and positive likelihood ratios of the tests were determined. Sputum specimens and bronchoalveolar lavage fluid were sent for mycobacterial culture, Xpert MTB/RIF assay, and cell-free M. tuberculosis DNA or RNA assay. Blood samples were used for IGRAs, T-cell counts (CD3 + CD4+ and CD3 + CD8+), and antibodies to tuberculosis test. RESULTS: Of the 1857 participants enrolled in this study, 1772 were included in the analyses, among which, 1311 were diagnosed with active tuberculosis. The specificity of antibody against 16kD for active tuberculosis was 92.7% (95% confidence interval [CI]: 89.3–95.4) with a positive likelihood ratio for active tuberculosis cases of 3.1 (95% CI: 2.1–4.7), which was higher than that of antibody to Rv1636 (90.5% [95% CI: 86.6–93.5]), antibody to 38kD (89.5% [95% CI: 85.5–92.7]), antibody against CFP-10 (82.6% [95% CI: 77.9–86.7]), and antibody against LAM (79.3% [95% CI: 74.3–83.7]). Sensitivity ranged from 15.8% (95% CI: 13.9–17.9) for antibody against Rv1636 to 32.9% (95% CI: 30.4–35.6) for antibody to LAM. CONCLUSIONS: Commercially available antibodies against to Mycobacterium tuberculosis do not have sufficient sensitivity for the diagnostic evaluation of active tuberculosis. However, antibody against Rv1636 and 16kD may have sufficiently high specificities, high positive likelihood ratios, and correspondingly high positive predictive values to facilitate the rule-in of active tuberculosis. Taylor & Francis 2023-07-21 /pmc/articles/PMC10364559/ /pubmed/37477876 http://dx.doi.org/10.1080/07853890.2023.2238186 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Infectious Diseases Bi, DeWu Liang, ChaoJuan Huang, XiaoXian Pan, HuiDan Qin, Yue Shi, XiMing Tang, YunHua Wang, Ying Zhao, MingMei Lin, JianYan Xie, ZhouHua Wen, LeMin Chen, ChaoYou Tang, XiKe Luo, XiaoCheng Shao, HongHua Luo, XiaoLu Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title | Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title_full | Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title_fullStr | Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title_full_unstemmed | Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title_short | Clinical utilization of multiple antibodies of Mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
title_sort | clinical utilization of multiple antibodies of mycobacterium tuberculosis for serodiagnosis evaluation of tuberculosis: a retrospective observational cohort study |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364559/ https://www.ncbi.nlm.nih.gov/pubmed/37477876 http://dx.doi.org/10.1080/07853890.2023.2238186 |
work_keys_str_mv | AT bidewu clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT liangchaojuan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT huangxiaoxian clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT panhuidan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT qinyue clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT shiximing clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT tangyunhua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT wangying clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT zhaomingmei clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT linjianyan clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT xiezhouhua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT wenlemin clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT chenchaoyou clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT tangxike clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT luoxiaocheng clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT shaohonghua clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy AT luoxiaolu clinicalutilizationofmultipleantibodiesofmycobacteriumtuberculosisforserodiagnosisevaluationoftuberculosisaretrospectiveobservationalcohortstudy |